# Milestone Pharmaceuticals Inc.

Organization · id `cardio:org-milestone-pharmaceuticals-inc` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Milestone+Pharmaceuticals+Inc.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Milestone Pharmaceuticals Inc.
- Sponsor class: OTHER

## Connected pages

- Sponsors: Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm (`cardio:ct-nct02296190`)
- Sponsors: Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). (`cardio:ct-nct03464019`)
- Sponsors: Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302 (`cardio:ct-nct03635996`)
- Sponsors: Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303 (`cardio:ct-nct04072835`)
- Sponsors: Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia (`cardio:ct-nct04952610`)
- Sponsors: Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (`cardio:ct-nct05410860`)
- Sponsors: ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3 (`cardio:ct-nct06716021`)

## Provenance

Content hash: fa3100748e4549154deacafa1faab51f463da316638a5f92265d868b79739b60
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
